HALEOSLABS1,450.00

HALEOS LABS LIMITED

· Pharma & Health
₹ CrorePeersALBERTDAVDVALIANTLABMEDICOMEDICAMEQZIMLABAAREYDRUGSNECLIFEANUHPHRMcap ₹438 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment220.9230.0266.5266.5
+ Capital Work-in-Progress6.00.410.410.4
+ Other Intangibles0.00.10.00.0
+ Non-current Investments0.00.00.00.0
+ Other Non-current Financial Assets3.13.34.64.6
Non-current Financial Assets3.23.34.64.6
+ Other Non-current Assets5.15.79.79.7
Total Non-current Assets235.2239.4291.3291.3
Current Assets
+ Inventories81.267.479.879.8
+ Trade Receivables51.468.861.361.3
+ Cash & Cash Equivalents0.60.51.21.2
+ Other Bank Balances0.91.01.21.2
Current Financial Assets52.870.363.763.7
+ Other Current Assets21.212.717.817.8
Total Current Assets155.3150.6163.1163.1
Total Assets390.5390.0454.4454.4
Equity
+ Equity Share Capital3.03.03.03.0
+ Other Equity / Reserves173.8193.5210.5210.5
Equity — Owners of Parent176.8196.6213.5213.5
+ Minority Interest16.815.516.016.0
Total Equity193.6212.0229.6229.6
Liabilities
+ Borrowings — Non-current33.118.350.050.0
+ Other Non-current Financial Liab0.80.8
Non-current Financial Liabilities33.118.350.850.8
+ Provisions — Non-current4.75.14.94.9
+ Deferred Tax Liabilities12.010.712.912.9
+ Other Non-current Liabilities2.41.7
Non-current Liabilities52.335.968.668.6
+ Borrowings — Current64.665.758.958.9
+ Trade Payables59.153.361.461.4
+ Other Current Financial Liab8.713.017.917.9
Current Financial Liabilities132.4132.0138.3138.3
+ Provisions — Current1.71.61.91.9
+ Other Current Liabilities10.58.416.116.1
Current Liabilities144.6142.1156.3156.3
Total Liabilities196.9177.9224.9224.9
Total Equity & Liabilities390.5390.0454.4454.4
Assets — additional as-filed lines
+ Current Tax Assets0.10.21.81.8
Trade Payables — MSME split
+ Dues to Micro & Small — Current1.21.01.0
+ Dues to Other Creditors — Current52.160.460.4
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.